[Trisomy 21 screening: value of ultrasound and serum markers in a combined approach]

J Gynecol Obstet Biol Reprod (Paris). 2001 Feb;30(1):11-27.

[Article in French]

Authors

M V Senat¹, P Rozenberg, J P Bernard, Y Ville

Affiliation

¹ Service de Gynécologie Obstétrique, CHI Poissy-Saint-Germain, BP 3082, 10, rue de Champ-Gaillard, 78303 Poissy Cedex.

PMID: 11240502

No abstract available

Publication types

Review

MeSH terms

Algorithms
Biomarkers / blood
Chorionic Gonadotropin, beta Subunit, Human / blood*
Decision Trees
Down Syndrome / blood*
Down Syndrome / diagnosis*
Down Syndrome / etiology
Estriol / blood*
Female
Gestational Age
Humans
Mass Screening / methods*
Maternal Age
Patient Selection
Pregnancy
Pregnancy Trimester, First
Pregnancy-Associated Plasma Protein-A / metabolism*
Prenatal Diagnosis / methods*
Reproducibility of Results
Risk Factors
Sensitivity and Specificity
Ultrasonography, Prenatal / methods*
alpha-Fetoproteins / metabolism*

Substances

Biomarkers
Chorionic Gonadotropin, beta Subunit, Human
alpha-Fetoproteins
Pregnancy-Associated Plasma Protein-A
Estriol